Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)
267.00 x 1 326.00 x 8
Post-market by (Cboe BZX)
292.82 +8.57 (+3.01%) 04/22/25 [NASDAQ]
267.00 x 1 326.00 x 8
Post-market 292.82 unch (unch) 16:20 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
286.34
Day High
293.55
Open 288.64
Previous Close 284.25 284.25
Volume 365,900 365,900
Avg Vol 457,995 457,995
Stochastic %K 43.69% 43.69%
Weighted Alpha +6.63 +6.63
5-Day Change +8.51 (+2.99%) +8.51 (+2.99%)
52-Week Range 233.27 - 417.82 233.27 - 417.82
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,766,234
  • Shares Outstanding, K 44,912
  • Annual Sales, $ 2,877 M
  • Annual Income, $ 1,195 M
  • EBIT $ 1,377 M
  • EBITDA $ 1,450 M
  • 60-Month Beta 0.63
  • Price/Sales 4.44
  • Price/Cash Flow 10.03
  • Price/Book 1.97

Options Overview Details

View History
  • Implied Volatility 43.02% ( -1.39%)
  • Historical Volatility 37.70%
  • IV Percentile 96%
  • IV Rank 69.44%
  • IV High 52.79% on 04/08/25
  • IV Low 20.82% on 05/09/24
  • Put/Call Vol Ratio 7.82
  • Today's Volume 397
  • Volume Avg (30-Day) 374
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 4,858
  • Open Int (30-Day) 4,458

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 6.29
  • Number of Estimates 8
  • High Estimate 7.07
  • Low Estimate 5.76
  • Prior Year 6.17
  • Growth Rate Est. (year over year) +1.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
266.98 +9.68%
on 04/09/25
Period Open: 312.99
322.32 -9.15%
on 03/25/25
-20.17 (-6.44%)
since 03/21/25
3-Month
266.98 +9.68%
on 04/09/25
Period Open: 371.28
383.51 -23.65%
on 02/19/25
-78.46 (-21.13%)
since 01/22/25
52-Week
233.27 +25.53%
on 04/24/24
Period Open: 234.06
417.82 -29.92%
on 11/08/24
+58.76 (+25.10%)
since 04/22/24

Most Recent Stories

More News
2 of Wall Street’s Favorite Stocks to Target This Week and 1 to Question

2 of Wall Street’s Favorite Stocks to Target This Week and 1 to Question

EPC : 30.42 (+1.37%)
KRT : 24.94 (+2.21%)
UTHR : 292.82 (+3.01%)
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4

BMRN : 61.50 (+4.86%)
VRTX : 490.47 (+2.71%)
MRNA : 25.74 (+2.43%)
UTHR : 292.82 (+3.01%)
BIIB : 118.89 (+2.06%)
3 Reasons Investors Watch United Therapeutics (UTHR)

3 Reasons Investors Watch United Therapeutics (UTHR)

UTHR : 292.82 (+3.01%)
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 61.50 (+4.86%)
VRTX : 490.47 (+2.71%)
MRNA : 25.74 (+2.43%)
UTHR : 292.82 (+3.01%)
BIIB : 118.89 (+2.06%)
2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

CHE : 579.50 (+2.82%)
HIMS : 25.35 (-1.90%)
UTHR : 292.82 (+3.01%)
2 Value Stocks on Our Watchlist and 1 to Ignore

2 Value Stocks on Our Watchlist and 1 to Ignore

DHI : 124.96 (+3.48%)
UTHR : 292.82 (+3.01%)
PRKS : 45.01 (+4.43%)
Why United Therapeutics (UTHR) Stock Is Down Today

Why United Therapeutics (UTHR) Stock Is Down Today

UTHR : 292.82 (+3.01%)
United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations

United Therapeutics (NASDAQ:UTHR) Reports Q4 In Line With Expectations

UTHR : 292.82 (+3.01%)
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 292.82 (+3.01%)
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

MYGN : 7.43 (+0.41%)
BMRN : 61.50 (+4.86%)
UTHR : 292.82 (+3.01%)
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?

United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?

UTHR : 292.82 (+3.01%)
Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease.This...

JNJ : 157.75 (+0.53%)
MRK : 78.97 (+1.44%)
UTHR : 292.82 (+3.01%)
1 AI Stock Cathie Wood Is Buying Instead of Tesla

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

TSLA : 237.97 (+4.60%)
ARKG : 21.30 (+4.26%)
TEM : 43.23 (+5.49%)
UTHR : 292.82 (+3.01%)
ARKK : 46.12 (+3.78%)
BNTX : 104.68 (+2.82%)
Insider Sale: PRESIDENT AND COO of $UTHR (UTHR) Sells 100 Shares

MICHAEL BENKOWITZ, the PRESIDENT AND COO of $UTHR ($UTHR), sold 100 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0%...

UTHR : 292.82 (+3.01%)
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study

Key TakeawaysMerck's stock rose 2% Monday on the back of positive data from a study of a new hypertension drug.MRK stock has declined 7% so far this year, compared to a 5.7% increase for the wider pharmaceutical...

JNJ : 157.75 (+0.53%)
MRK : 78.97 (+1.44%)
PFE : 22.53 (+2.22%)
UTHR : 292.82 (+3.01%)
United Therapeutics: Q3 Earnings Snapshot

United Therapeutics: Q3 Earnings Snapshot

UTHR : 292.82 (+3.01%)
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 292.82 (+3.01%)
Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans.

Whether you'd like to invest like Nancy Pelosi or Ted Cruz, you can. But maybe you shouldn't.

MSFT : 366.82 (+2.14%)
NVDA : 98.89 (+2.04%)
GOOG : 153.90 (+2.70%)
AAPL : 199.74 (+3.41%)
ANET : 68.67 (+1.48%)
FIX : 340.33 (+3.71%)
JPM : 235.59 (+2.88%)
CRUZ : 21.86 (+2.09%)
NANC : 34.30 (+2.73%)
AMZN : 173.18 (+3.50%)
UTHR : 292.82 (+3.01%)
Chart of the Day: United Therapeutics - Drugs for Chronic Illnesses

The Chart of the Day belongs to the pharmaceutical company United Therapeutics (UTHR) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

UTHR : 292.82 (+3.01%)
United Therapeutics: Q1 Earnings Snapshot

United Therapeutics: Q1 Earnings Snapshot

UTHR : 292.82 (+3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 302.67
2nd Resistance Point 298.11
1st Resistance Point 295.47
Last Price 292.82
1st Support Level 288.26
2nd Support Level 283.70
3rd Support Level 281.05

See More

52-Week High 417.82
Fibonacci 61.8% 347.32
Fibonacci 50% 325.54
Fibonacci 38.2% 303.77
Last Price 292.82
52-Week Low 233.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.